Use of monoclonal antibody B72. 3 in the management of gynecologic malignancies
Journal Article
·
· Yale J. Biol. Med.; (United States)
OSTI ID:6604209
Monoclonal antibodies are currently used in the diagnosis of gynecologic malignancies by way of immunohistochemical assays, serum assays, and in situ radiolocalization of carcinoma lesions. Among them is MAb B72.3, generated against a human tumor-associated antigen (TAG-72). Using immunohistochemical techniques, MAb B72.3 has shown reactivity with 100 percent of common epithelial ovarian carcinomas and endometrial carcinomas and non-reactivity with normal adult tissues, with the exception of normal secretory endometrium. B72.3 appears to be a valuable immunocytologic adjunct, with greater than 90 percent of effusions and fine-needle aspiration biopsies from gynecologic carcinomas showing reactivity. Using a serum assay developed to detect the presence of the TAG-72 antigen, 48 percent of patients with ovarian carcinoma demonstrated TAG-72-positive sera versus 1 percent of control sera. /sup 131/I-labeled MAb B72.3 IgG and gamma scanning have been used for the in situ detection of metastatic carcinoma. Twelve of 15 patients with ovarian carcinoma showed positive gamma scans, and approximately 80 percent of the lesions demonstrated specific localization of the antibody. These studies indicate the potential utility of MAb B72.3 in the diagnosis of gynecologic carcinoma. 57 references.
- Research Organization:
- National Cancer Institute, Bethesda, MD (USA)
- OSTI ID:
- 6604209
- Journal Information:
- Yale J. Biol. Med.; (United States), Journal Name: Yale J. Biol. Med.; (United States) Vol. 61:4; ISSN YJBMA
- Country of Publication:
- United States
- Language:
- English
Similar Records
In vivo fate of monoclonal antibody B72. 3 in patients with colorectal cancer
Biodistribution of monoclonal antibody B72. 3(I-131) in colon cancer patients
Radioimmunolocalization of human carcinoma xenografts with B72. 3 second generation monoclonal antibodies
Journal Article
·
Sun Jul 01 00:00:00 EDT 1990
· Journal of Nuclear Medicine; (USA)
·
OSTI ID:6872504
Biodistribution of monoclonal antibody B72. 3(I-131) in colon cancer patients
Conference
·
Wed May 01 00:00:00 EDT 1985
· J. Nucl. Med.; (United States)
·
OSTI ID:7031967
Radioimmunolocalization of human carcinoma xenografts with B72. 3 second generation monoclonal antibodies
Journal Article
·
Mon Aug 15 00:00:00 EDT 1988
· Cancer Res.; (United States)
·
OSTI ID:6924350
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIBODIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARBOHYDRATES
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC USES
DISEASES
DOCUMENT TYPES
FEMALE GENITALS
GLUCOPROTEINS
GLYCOPROTEINS
GONADS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPES
MONOCLONAL ANTIBODIES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANS
OVARIES
PATIENTS
PROTEINS
RADIOISOTOPES
REVIEWS
SACCHARIDES
USES
UTERUS
62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIBODIES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARBOHYDRATES
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DIAGNOSIS
DIAGNOSTIC USES
DISEASES
DOCUMENT TYPES
FEMALE GENITALS
GLUCOPROTEINS
GLYCOPROTEINS
GONADS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPES
MONOCLONAL ANTIBODIES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANS
OVARIES
PATIENTS
PROTEINS
RADIOISOTOPES
REVIEWS
SACCHARIDES
USES
UTERUS